A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Statin use linked to better survival but higher cardiac adverse events in advanced prostate cancer patients treated with ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

Adding Xtandi to androgen deprivation therapy and radiation did not significantly improve metastasis-free survival in ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.